Cargando…

Hyperglycemic conditions inhibit C3-mediated immunologic control of Staphylococcus aureus

BACKGROUND: Diabetic patients are at increased risk for bacterial infections; these studies provide new insight into the role of the host defense complement system in controlling bacterial pathogens in hyperglycemic environments. METHODS: The interactions of complement C3 with bacteria in elevated g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hair, Pamela S, Echague, Charlene G, Rohn, Reuben D, Krishna, Neel K, Nyalwidhe, Julius O, Cunnion, Kenji M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328285/ https://www.ncbi.nlm.nih.gov/pubmed/22390383 http://dx.doi.org/10.1186/1479-5876-10-35

Ejemplares similares

Hyperglycemia Inhibits Complement-Mediated Immunological Control of S. aureus in a Rat Model of Peritonitis
por: Mauriello, Clifford T., et al.
Publicado: (2014)

Staphylococcus aureus Surface Protein SdrE Binds Complement Regulator Factor H as an Immune Evasion Tactic
por: Sharp, Julia A., et al.
Publicado: (2012)

Peptide Inhibitor of Complement C1 Inhibits the Peroxidase Activity of Hemoglobin and Myoglobin
por: Hair, Pamela S., et al.
Publicado: (2017)

Classical complement pathway inhibition reduces brain damage in a hypoxic ischemic encephalopathy animal model
por: Kumar, Parvathi, et al.
Publicado: (2021)

Inhibition of complement activation, myeloperoxidase, NET formation and oxidant activity by PIC1 peptide variants
por: Hair, Pamela S., et al.
Publicado: (2019)

Inhibition of Myeloperoxidase Activity in Cystic Fibrosis Sputum by Peptide Inhibitor of Complement C1 (PIC1)
por: Hair, Pamela S., et al.
Publicado: (2017)

Inhibition of Immune Complex Complement Activation and Neutrophil Extracellular Trap Formation by Peptide Inhibitor of Complement C1
por: Hair, Pamela S., et al.
Publicado: (2018)

Peptide inhibition of neutrophil-mediated injury after in vivo challenge with supernatant of Pseudomonas aeruginosa and immune-complexes
por: Enos, Adrianne, et al.
Publicado: (2021)

Peptide Inhibitor of Complement C1 (PIC1) demonstrates antioxidant activity via single electron transport (SET) and hydrogen atom transfer (HAT)
por: Gregory Rivera, Magdielis, et al.
Publicado: (2018)

Peptide Inhibitor of Complement C1 (PIC1) Rapidly Inhibits Complement Activation after Intravascular Injection in Rats
por: Sharp, Julia A., et al.
Publicado: (2015)

Complement effectors, C5a and C3a, in cystic fibrosis lung fluid correlate with disease severity
por: Hair, Pamela S., et al.
Publicado: (2017)

Complement Effectors of Inflammation in Cystic Fibrosis Lung Fluid Correlate with Clinical Measures of Disease
por: Sass, Laura A., et al.
Publicado: (2015)

CcpA Affects Infectivity of Staphylococcus aureus in a Hyperglycemic Environment
por: Bischoff, Markus, et al.
Publicado: (2017)

Role of Molecular Diagnostics in the Management of Infectious Disease Emergencies
por: Krishna, Neel K., et al.
Publicado: (2012)

Clinical hypothermia temperatures increase complement activation and cell destruction via the classical pathway
por: Shah, Tushar A, et al.
Publicado: (2014)

Delayed Hemolytic Transfusion Reaction in a Patient With Sickle Cell Disease and the Role of the Classical Complement Pathway: A Case Report
por: Hair, Pamela S., et al.
Publicado: (2021)

Peptide Inhibitor of Complement C1, a Novel Suppressor of Classical Pathway Activation: Mechanistic Studies and Clinical Potential
por: Sharp, Julia A., et al.
Publicado: (2014)

Peptide Inhibitor of Complement C1, RLS-0071, Reduces Zosteriform Spread of Herpes Simplex Virus Type 1 Skin Infection and Promotes Survival in Infected Mice
por: Bhutta, Maimoona S., et al.
Publicado: (2021)

The EPICC Family of Anti-Inflammatory Peptides: Next Generation Peptides, Additional Mechanisms of Action, and In Vivo and Ex Vivo Efficacy
por: Krishna, Neel K., et al.
Publicado: (2022)

Peptide inhibition of acute lung injury in a novel two-hit rat model
por: Sampson, Alana C., et al.
Publicado: (2021)

RLS-0071 Moderated Elevated Myeloperoxidase Level and Activity in an Asymptomatic Subject in Clinical Trial RLS-0071-101
por: Goss, Jessica M., et al.
Publicado: (2023)

997. RLS-0071 Improves Survival in a Rat Model of Intestinal Necrosis
por: Cunnion, Kenji, et al.
Publicado: (2021)

CHEMICAL BASIS FOR AN IMMUNOLOGICAL SPECIFICITY OF A STRAIN OF STAPHYLOCOCCUS AUREUS
por: Juergens, William G., et al.
Publicado: (1963)

The role of Staphylococcus aureus in atopic dermatitis: microbiological and immunological implications
por: Tomczak, Hanna, et al.
Publicado: (2019)

L-Carnitine: An Antioxidant Remedy for the Survival of Cardiomyocytes under Hyperglycemic Condition
por: Vacante, Fernanda, et al.
Publicado: (2018)

O-GlcNAcylation of GLI Transcription Factors in Hyperglycemic Conditions Augments Hedgehog activity: Hyperglycemic conditions upregulate GLI activity
por: Das, Shamik, et al.
Publicado: (2018)

Immunological role of nasal staphylococcus aureus carriage in patients with persistent allergic rhinitis
por: Refaat, Maged Mohamed, et al.
Publicado: (2008)

Incompatible erythrocyte transfusion with lipopolysaccharide induces acute lung injury in a novel rat model
por: Gregory Rivera, Magdielis, et al.
Publicado: (2020)

Inhibition of HMGB1 Promotes Osseointegration under Hyperglycemic Condition through Improvement of BMSC Dysfunction
por: Liu, Beilei, et al.
Publicado: (2019)

Ceftriaxone-Induced Immune Hemolytic Anemia: In Vitro Reversal with Peptide Inhibitor of Complement C1 (PIC1)
por: Cunnion, Kenji M., et al.
Publicado: (2019)

Lysine Inhibits Hemolytic Activity of Staphylococcus aureus and Its Application in Food Model Contaminated with Staphylococcus aureus
por: Wan, Yangli, et al.
Publicado: (2022)

Selenium nanoparticles inhibit Staphylococcus aureus growth
por: Tran, Phong A, et al.
Publicado: (2011)

Viability of primary cultured retinal neurons in a hyperglycemic condition
por: Liu, Yu, et al.
Publicado: (2013)

Molecular and Immunological Characterization of Staphylococcus aureus in Pediatric Atopic Dermatitis: Implications for Prophylaxis and Clinical Management
por: Pascolini, Chiara, et al.
Publicado: (2011)

Distinct T-helper cell responses to Staphylococcus aureus bacteremia reflect immunologic comorbidities and correlate with mortality
por: Greenberg, Jared A., et al.
Publicado: (2018)

Hyperglycemic chorea
por: Sasaki, Tokio, et al.
Publicado: (2021)

Transcriptional Response of Staphylococcus aureus to Sunlight in Oxic and Anoxic Conditions
por: McClary, Jill S., et al.
Publicado: (2018)

The complex regulation of competence in Staphylococcus aureus under microaerobic conditions
por: Feng, Shi Yuan, et al.
Publicado: (2023)

Methicillin-resistant Staphylococcus aureus in Nepal
por: Shrestha, Lok Bahadur, et al.
Publicado: (2021)

Epidemiology of Staphylococcus aureus Non-Susceptible to Vancomycin in South Asia
por: Ejaz, Mohammad, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sd5lnfns00hg2j7585191hpvi7